What are the key differences between Amgen (AMGN) and Johnson & Johnson (JNJ)?

Compare Amgen (AMGN) and Johnson & Johnson (JNJ) side by side on Lunoo to see detailed feature differences, AI scores, and expert analysis.

How are Amgen (AMGN) and Johnson & Johnson (JNJ) scored?

Amgen (AMGN) has an AI score of 7.9/10 and Johnson & Johnson (JNJ) has an AI score of 9.5/10. Scores are based on features, user satisfaction, and overall quality analysis.

Amgen (AMGN) vs Johnson & Johnson (JNJ) 2026 — Compared

Amgen (AMGN)

Johnson & Johnson (JNJ)

WINNER Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ) edges ahead with a score of 9.5/10 compared to 7.9/10 for Amgen (AMGN). While both are highly ra...

Amgen (AMGN)

7.9 Good

Dividend Stocks Get Amgen (AMGN) open_in_new

emoji_events WINNER

Johnson & Johnson (JNJ)

9.5 Brilliant

Dividend Stocks Get Johnson & Johnson (JNJ) open_in_new

psychology AI Verdict

Johnson & Johnson (JNJ) edges ahead with a score of 9.5/10 compared to 7.9/10 for Amgen (AMGN). While both are highly rated in their respective fields, Johnson & Johnson (JNJ) demonstrates a slight advantage in our AI ranking criteria. A detailed AI-powered analysis is being prepared for this comparison.

emoji_events Winner: Johnson & Johnson (JNJ)

verified Confidence: Low

Ready to decide? Get Johnson & Johnson (JNJ) arrow_forward

description Overview

Amgen (AMGN)

Amgen is a leading biotechnology company focused on developing and manufacturing innovative medicines. The company's portfolio includes therapies for serious illnesses. Amgen has a history of dividend increases and is committed to shareholder returns. Its research and development pipeline aims to drive future growth. The current dividend yield is approximately 3.1%.

Johnson & Johnson (JNJ)

Johnson & Johnson is a diversified healthcare company operating in pharmaceuticals, medical devices, and consumer health. Its diverse business segments provide resilience against economic fluctuations and sector-specific challenges. Like P&G, J&J is a Dividend Aristocrat with a long history of dividend increases. While the company recently spun off its consumer health division (Kenvue), the rem...